1. The impact of Girdin expression on recurrence-free survival in patients with luminal-type breast cancer

   • Kazumi Nishimae
   • Nobuyuki Tsunoda
   • Masato Nagino

   Original Article 24 October 2013 Pages: 445 - 451

   

2. Relationship of serum isoflavone, insulin and adiponectin levels with breast cancer risk

   • Machiko Minatoya
   • Goro Kutomi
   • Koichi Hirata

   Original Article 29 October 2013 Pages: 452 - 461

3. Prevalence and differentiation of hereditary breast and ovarian cancers in Japan

   • Seigo Nakamura
   • Masato Takahashi
   • Tadao Shimizu

   Original Article 19 November 2013 Pages: 462 - 468

   

4. Radiation exposure during sentinel lymph node biopsy for breast cancer: effect on pregnant female physicians

   • Fuyo Kimura
   • Mana Yoshimura
   • Norio Kohno

   Original Article 30 October 2013 Pages: 469 - 474

   

5. Earlier and better high-resolution single breast imaging during bilateral breast dynamic scans at 3-T MRI: comparison with post dynamic high-resolution imaging

   • Fumi Kato
   • Noriko Oyama-Manabe
   • Hiroki Shirato

   Original Article 31 October 2013 Pages: 475 - 479

   

6. Nine weeks versus 1 year adjuvant trastuzumab in patients with early breast cancer: an observational study by the Turkish Oncology Group (TOG)

   • Fikri İçli
   • Kadri Altundağ
   • Ali Arican

   Original Article 12 December 2013 Pages: 480 - 485

   

7. Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG

   • Katsumasa Kuroi
   • Masakazu Toi
   • Futoshi Akiyama

   Original Article 14 December 2013 Pages: 486 - 495

   

8. Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer

   • Ken Yamaguchi
   • Hiroyuki Abe
   • Hiroyuki Irie

   Original Article 09 January 2014 Pages: 496 - 502

   

9. Brain metastases in HER2-positive metastatic breast cancer patients who received chemotherapy with or without trastuzumab

   • Muhammet Ali Kaplan
   • Hamza Ertugrul
   • Abdurrahman Isikdogan

   Original Article 03 January 2014 Pages: 503 - 509

10. Feasibility of MR spectroscopy for characterizing malignant breast lesions using a clinical 3-T scanner

    • Hyeon-Man Baek
    • Yun-Ju Lee

    Original Article 04 January 2014 Pages: 510 - 519

    

11. Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer

    • Yuichi Hisamatsu
    • Eriko Tokunaga
    • Yoshihiko Maehara

    Original Article 11 January 2014 Pages: 520 - 528

    

12. A novel diagnostic method targeting genomic instability in intracystic tumors of the breast

    • Masahiro Oikawa
    • Hiroshi Yano
    • Takeshi Nagayasu

    Original Article 09 January 2014 Pages: 529 - 535

    

13. Survival analysis of patients with unilateral and bilateral primary breast cancer in Northeast China

    • Ying Xing
    • Qingwei Meng
    • Li Cai

    Original Article 08 February 2014 Pages: 536 - 543

    

14. Evaluating 17 breast cancer susceptibility loci in the Nashville breast health study

    • Mi-Ryung Han
    • Sandra Deming-Halverson
    • Jirong Long

    Original Article 09 February 2014 Pages: 544 - 551

15. Two cases of diabetic mastopathy: MR imaging and pathological correlation

    • Hatsuko Nasu
    • Akiko Ikeda
    • Harumi Sakahara

    Case Report 14 September 2012 Pages: 552 - 556

    

16. A case of familial breast cancer with double heterozygosity for BRCA1 and BRCA2 genes

    • Tadashi Nomizu
    • Masami Matsuzaki
    • Yoshiko Yamaguchi

    Case Report 15 December 2012 Pages: 557 - 561